Danaher Corporation (DHR) Q4 2025 (USD): Adj EPS 2.23 (exp. 2.16), Revenue 6.84bln (exp. 6.80bln), Current FY EPS 7.80 (exp. 7.73), Next FY EPS 8.50 (exp. 8.42)
Importance
Level 1
- Biotechnology Revenue 2.03bln (exp. 2.03bln)
- Life Sciences 2.09bln (exp. 2.07bln)
#DANAHER CORP#DHR.US#IMPORTANT#EQUITIES#EU SESSION#LIFE SCIENCES TOOLS & SERVICES#LIFE SCIENCES TOOLS & SERVICES (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DHR#US EQUITIES